EVA1B and central nervous system cancer: Receiver operating characteristic (ROC) analysis was performed to compare the predictive power between <i>EVA1B</i> and other commonly immune-related markers.<h4>Results</h4>In the CGGA cohort of 325 glioma patients, we found that <i>EVA1B</i> was upregulated in glioma, and increased with tumor grade.